ESR1 and neoplasm: As hypothesized by Gou and colleagues (81), these transcriptionally inactive ESR1-e6>fusions could (1) encode tumor suppressors, (2) be active exclusively in the presence of a specific set of coactivators, or (3) act as dominant negative regulators interrupting the function of the remaining intact wild-type protein activity.